Clinical Trial Update: Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating spironolactone for fibrosis progression in portal hypertension associated with cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Portal Hypertension

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Changqing Yang | Conditions: Cirrhosis, Portal Hypertension | Phase 4 | Status: COMPLETED